SCHEMBL21541353

SCHEMBL21541353

Bc1ccc(C(=O)OCC)c2nc(S)oc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
TSHR P16473 1/20 0.41
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
TARBP2 Q15633 5/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP1A2 P05177 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MIF P14174 1/20 0.38
PFKFB3 Q16875 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21487580 0.84 MAOB (0.43) ESR1ESR2TSHRMAOAMAOB
SCHEMBL21603092 0.77 MAOB (0.38) ESR1ESR2TSHRMAOAMAOB
SCHEMBL23315376 0.72 CA12 (0.42) ESR1ESR2TSHRMAOATARBP2
SCHEMBL21487622 0.70 MAOB (0.42) ESR1ESR2TSHRMAOAMAOB
SCHEMBL21487900 0.69 MAOB (0.43) ESR1ESR2TSHRMAOAMAOB
SCHEMBL27577813 0.69 ESR1 (0.49) ESR1ESR2TSHRMAOAMAOB
SCHEMBL6010927 0.69 ESR1 (0.49) ESR1ESR2TSHRMAOAMAOB
SCHEMBL21541355 0.69 NQO2 (0.38) ESR1ESR2TSHRCA12CA1
SCHEMBL21487790 0.68 KMT2A (0.37) ESR2TSHRCA12CA1CA2
SCHEMBL11734958 0.67 MEN1 (0.54) TSHRCA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560925-B1 NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF MEIJI SEIKA PHARMA CO LTD (JP) 2021-06-02 EP disclosed
EP-3560925-A1 NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF Meiji Seika Pharma Co., Ltd. (JP) 2019-10-30 EP disclosed